INTEGRATIVE MANAGEMENT OF JALODARA (ASCITES) SECONDARY TO CHRONIC LIVER DISEASE – A CASE REPORT
International Ayurvedic Medical Journal · 26.03.2026 · 939
DOI: 10.46607/iamj3214032026 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Ayurvedic Medical Journal, online erschienen am 25.03.2026. Verfasst von Vidya G Mohan. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Jalodara (ascites) is a severe form of Udara Roga described in Ayurveda, resulting from impaired Agni, Sroto-dushti and Yakrit dysfunction. Ascites secondary to chronic liver disease is associated with poor prognosis, fre-quent recurrence and limited long-term success when managed with conventional therapy alone. The present case report documents the successful integrative management of a 42-year-old male with gross ascites, hepato-splenomegaly, portal hypertension and jaundice using a combined approach of Ayurvedic therapeutics and sup-portive modern care, including herbo-mineral formulations, Nitya Virechana, Mutrala therapy and therapeutic paracentesis. A marked reduction in abdominal girth and pedal oedema, and an improvement in overall clinical status, were observed. This case highlights the role of Ayurveda as a disease-modifying system within an inte-grative framework for the management of ascites by correcting Yakrit-dushti, Agnimandya and Srotorodha.
Zitieren
APA
Mohan, V. G. (2026). INTEGRATIVE MANAGEMENT OF JALODARA (ASCITES) SECONDARY TO CHRONIC LIVER DISEASE – A CASE REPORT. International Ayurvedic Medical Journal, 939. https://doi.org/10.46607/iamj3214032026
Vancouver
Mohan VG. INTEGRATIVE MANAGEMENT OF JALODARA (ASCITES) SECONDARY TO CHRONIC LIVER DISEASE – A CASE REPORT. International Ayurvedic Medical Journal. 2026:939. doi:10.46607/iamj3214032026
BibTeX
@article{Mohan2026,
author = {Mohan, Vidya G},
title = {INTEGRATIVE MANAGEMENT OF JALODARA (ASCITES) SECONDARY TO CHRONIC LIVER DISEASE – A CASE REPORT},
journal = {International Ayurvedic Medical Journal},
year = {2026},
pages = {939},
doi = {10.46607/iamj3214032026}
}
EUVIMED